Article Details

RegeneRx Issues Letter To Stockholders

Retrieved on: 2021-07-22 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

RegeneRx Issues Letter To Stockholders. View article details on hiswai:

Excerpt

About RegeneRx Biopharmaceuticals, Inc. RegeneRx is focused on the development of novel therapeutic peptides, including Thymosin beta 4 (Tβ4) ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up